-
FDA panel recommends Moderna vaccine for children 6 and older
After a daylong meeting, an FDA panel voted 22-0 June 14 recommending the Moderna vaccine for children as young as 6, according to Politico. -
3 notes on the Novavax COVID-19 vaccine
As the potential fourth vaccine for COVID-19 passes benchmarks after months of delays and halted funding at the end of 2021, The Hill summarized three facts about Novavax June 14: -
Moderna's vaccine had fewer side effects than Pfizer's in study
An observational study of nearly half a million inoculated people found the Pfizer and Moderna COVID-19 vaccines had similar side effects, but the risk was lower in Moderna's. -
Vermont compounding pharmacy to settle misbranded drug allegations
Colchester, Va.-based pharmacy Edge Pharm agreed to ensure its products comply with the Federal Food, Drug and Cosmetic Act after allegations that it supplied misbranded and unadulterated drugs, the Justice Department said June 13. -
'It could be revolutionary': Researchers inch closer to cancer vaccine
Early research hints at the possibility of a vaccine for cancerous tumors, but the science is years away from regulators' approval, The Washington Post reported June 14. -
Paxlovid rebound symptoms rare, Mayo study finds
Less than 1 percent of the 483 high-risk patients who took Paxlovid experienced side effects, according to research published in Clinical Infectious Diseases on June 14. -
FDA approves 1st treatment for alopecia
The FDA approved the nation's first drug fighting severe hair loss with the approval of Eli Lilly and Incyte's systemic, daily pill June 13. -
Mail-order pharmacy dispenses abortion pills to 31 states
As some pharmacists hesitate to fill prescriptions for abortion pills as multiple states pass restrictive abortion laws, a 4-year-old online startup is "one of the nation's leading distributors of abortion pills," Time reported June 13. -
30 best over-the-counter health products, chosen by pharmacists
U.S. News & World Report, in partnership with the Pharmacy Times, issued its annual list of pharmacists' top recommended over-the-counter treatments and devices. -
Sanofi-GSK COVID-19 vaccine booster yields stronger result than Pfizer's in trial
In a phase 2/3 study, Sanofi-GSK's next-generation COVID-19 vaccine booster resulted in 76.1 percent of participants seeing at least a tenfold increase in neutralizing antibody titers. Pfizer's booster and Sanofi-GSK's first-generation vaccine trailed behind at 63.2 percent and 55.3 percent, respectively, according to the June 13 press release. -
2 updates on COVID-19 vaccine candidates for kids under 6 years
The FDA unveiled promising data for two COVID-19 vaccine candidates for children under 6 years. -
Mark Cuban's pharmacy adds 87 drugs
The Mark Cuban Cost Plus Drug Co. has added 87 generic drugs to its product list, the company said in a June 2 Facebook post. -
GSK's RSV vaccine shows promising results in clinical trial
London-based pharmaceutical company GSK revealed clinically meaningful phase 3 results from its respiratory syncytial virus vaccine candidate intended for adults 60 and older. -
FDA to get authority to pull fast-tracked drugs that don't work
With a 392-28 vote, the House of Representatives passed a bill June 8 intended to alter the FDA's accelerated-approval process after some "costly, ineffective drugs" hit pharmacy shelves, The Wall Street Journal reported. -
Novavax's COVID-19 vaccine could be postponed
Four days before an FDA panel endorsed the Novavax vaccine 21-0, the biotech company informed the FDA of changes to its manufacturing process, according to CNBC. -
Florida pharmacy owner ordered to pay $865K over insurance fraud scheme
A Kentucky federal court has sentenced Florida pharmacy owner Nitesh Patel to 12 months' probation and 12 months of home confinement and ordered him to pay more than $865,000 in restitution following his November guilty plea to one count of conspiracy to commit healthcare fraud. -
10 hospitals seeking pharmacy leaders
The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week. -
Memorial Hermann invests in sterile compounding pharmacy
Houston-based health system Memorial Hermann is the latest health system to invest in Leiters, a provider of sterile pharmacy services, June 9. -
3 pharmacy associations applaud FTC investigation into PBMs
National pharmaceutical groups congratulated the Federal Trade Commission's decision to investigate the business practices of the six largest pharmacy benefit managers about prescription drug access and affordability. -
Prescription drug costs hiked 20% annually for more than a decade, study finds
Brigham and Women's Hospital uncovered a stark finding in a study published June 7: Prices for new drugs at launch rose 20 percent each year between 2008 and 2021.
Page 49 of 50